|
|
Article: Yale BioHaven Entrepreneurship Seminars Begin with TheraLogics: "Starting a Drug Development Venture Without Venture Capital".
- Article from:
- M2 Presswire
- Article date:
- September 15, 2006
CopyrightCOPYRIGHT 2006 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-15 September 2006-YALE UNIVERSITY: Yale BioHaven Entrepreneurship Seminars Begin with TheraLogics: "Starting a Drug Development Venture Without Venture Capital"(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:14092006
New Haven, Conn. -- The Yale BioHaven Entrepreneurship Seminars series begins its fall schedule on Wednesday, September 20 from 3:30 to 5 p.m. in the Anlyan Center Auditorium of Yale Medical School, 300 Cedar Street.
This program will feature TheraLogics, Inc., a local technology start-up company that is unusual because it has not received -- and is not seeking -- venture capital investment.
Rather, it is funded ...